Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nemiralisib in Persistent Uncontrolled Asthma
NCT02567708Phase 2Completed
- Sponsor
- GSK
- Start
- Oct 2015
- Primary completion
- Sep 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of nemiralisib in asthma, sponsored by GSK. Started Oct 2015; status: completed.
02
Drugs
nemiralisib
03
Conditions
asthma
Beyond the preview
Go deeper on NCT02567708.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02567708.